Ataxia Telangiectasia Mutated and Rad3 Related (ATR) Protein Kinase Inhibition Is Synthetically Lethal in XRCC1 Deficient Ovarian Cancer Cells
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ataxia Telangiectasia Mutated and Rad3 Related (ATR) Protein Kinase Inhibition Is Synthetically Lethal in XRCC1 Deficient Ovarian Cancer Cells
Authors
Keywords
-
Journal
PLoS One
Volume 8, Issue 2, Pages e57098
Publisher
Public Library of Science (PLoS)
Online
2013-02-26
DOI
10.1371/journal.pone.0057098
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinicopathological and functional significance of XRCC1 expression in ovarian cancer
- (2012) Tarek Abdel-Fatah et al. INTERNATIONAL JOURNAL OF CANCER
- Synthetic lethal targeting of DNA double-strand break repair deficient cells by human apurinic/apyrimidinic endonuclease inhibitors
- (2012) Rebeka Sultana et al. INTERNATIONAL JOURNAL OF CANCER
- ATR signalling: more than meeting at the fork
- (2011) Edward A. Nam et al. BIOCHEMICAL JOURNAL
- Identification and evaluation of a potent novel ATR inhibitor, NU6027, in breast and ovarian cancer cell lines
- (2011) A Peasland et al. BRITISH JOURNAL OF CANCER
- Targeting the S and G2 checkpoint to treat cancer
- (2011) Tao Chen et al. DRUG DISCOVERY TODAY
- Targeting ATR and Chk1 kinases for cancer treatment: A new model for new (and old) drugs
- (2011) Luis I. Toledo et al. Molecular Oncology
- Base Excision Repair and Lesion-Dependent Subpathways for Repair of Oxidative DNA Damage
- (2010) David Svilar et al. ANTIOXIDANTS & REDOX SIGNALING
- Variation in base excision repair capacity
- (2010) David M. Wilson et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- Making the best of PARP inhibitors in ovarian cancer
- (2010) Susana Banerjee et al. Nature Reviews Clinical Oncology
- Functional capacity of XRCC1 protein variants identified in DNA repair-deficient Chinese hamster ovary cell lines and the human population
- (2010) Brian R. Berquist et al. NUCLEIC ACIDS RESEARCH
- DNA Repair in Mammalian Cells
- (2009) A. B. Robertson et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- DNA Repair in Mammalian Cells
- (2009) T. Nouspikel CELLULAR AND MOLECULAR LIFE SCIENCES
- Gastric Cardia Carcinoma is Associated with the Promoter -77T>C Gene Polymorphism of X-Ray Cross-Complementing Group 1 (XRCC1)
- (2009) Giovanni Corso et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Polymorphisms in XRCC1 and XPG and response to platinum-based chemotherapy in advanced non-small cell lung cancer patients
- (2009) Xinchen Sun et al. LUNG CANCER
- Increase the cisplatin cytotoxicity and cisplatin-induced DNA damage in HepG2 cells by XRCC1 abrogation related mechanisms
- (2009) Rong Zhang et al. TOXICOLOGY LETTERS
- Eukaryotic nucleotide excision repair: from understanding mechanisms to influencing biology
- (2008) Sarah C Shuck et al. CELL RESEARCH
- XRCC1 and DNA polymerase β in cellular protection against cytotoxic DNA single-strand breaks
- (2008) Julie K Horton et al. CELL RESEARCH
- Targeted therapy for cancer using PARP inhibitors
- (2008) Christopher J Lord et al. CURRENT OPINION IN PHARMACOLOGY
- XRCC1 Arginine194Tryptophan and GGH-401Cytosine/Thymine polymorphisms are associated with response to platinum-based neoadjuvant chemotherapy in cervical cancer
- (2008) Kidong Kim et al. GYNECOLOGIC ONCOLOGY
- ATR: an essential regulator of genome integrity
- (2008) Karlene A. Cimprich et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search